Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

751 studies match

clinicaltrialsPublishedShowing 351–400 of 751 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05352672	Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma	active not recruiting	Phase 3	1,546	Regeneron PharmaceuticalsINDUSTRY	24	Apr 22, 2026	clinicaltrials
NCT05687266	Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations(AVANZAR)	active not recruiting	Phase 3	1,350	AstraZenecaINDUSTRY